To Drill or Not to Drill: Do Memory Drills Help Train the Ability to "remember to Remember" in Veterans
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Oct 22, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial, titled "To Drill or Not to Drill," is studying whether a special technique called memory drilling can help veterans improve their ability to remember tasks they need to do later. The researchers want to find out if adding this memory drilling to standard memory training programs makes a difference in how well veterans can remember things. Participants in the study will either receive the usual memory training or the usual training plus memory drilling while they go through an intensive treatment program for PTSD or other issues.
To be eligible for the study, participants must be veterans who are scheduled to take part in the Operation Mend intensive treatment program. They should not have any recent substance abuse issues and must have access to a computer or tablet for the assessments. During the trial, participants will complete various memory tests when they start the program, when they finish, and again three months later. This will include surveys, interviews, and tasks designed to test their memory skills. The study is currently recruiting participants, and it aims to help improve memory support for veterans.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Only patients that are already accepted and scheduled to participate in an Operation Mend BRAIN Intensive Treatment Program and PTSD Intensive Treatment Program are eligible to participate in the study.
- Exclusion Criteria:
- • Patients with acute substance abuse disorders are not accepted into Operation Mend programs and are therefore excluded from the study.
- • For logistical reasons, patients who are scheduled for arrival at the ITP sooner than 2.5 or 3 weeks are not eligible to participate.
- • Patients who do not have tablet, iPad, or computer access are not eligible to participate due to the technical requirements of the computer-based assessments
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Delany Thrasher, PhD
Principal Investigator
University of California, Los Angeles
Kevin Bickart, MD, PhD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported